ELECTROMEDICAL TECHNOLOGIES, INC. Research and Development Expense
ELECTROMEDICAL TECHNOLOGIES, INC. (EMED) reported Research and Development Expense of $231.43 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-05-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2024-05-01
- ELECTROMEDICAL TECHNOLOGIES, INC. research and development expense for the quarter ending 2020-12-31 was $31.60K, a 33.11% decline year-over-year.
- ELECTROMEDICAL TECHNOLOGIES, INC. research and development expense for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- ELECTROMEDICAL TECHNOLOGIES, INC. research and development expense for the quarter ending 2020-06-30 was $4.00K, a 81.03% decline year-over-year.
- ELECTROMEDICAL TECHNOLOGIES, INC. research and development expense for the quarter ending 2019-12-31 was $47.24K.
- ELECTROMEDICAL TECHNOLOGIES, INC. research and development expense for fiscal 2023 was $231.43K, a 150.74% increase from fiscal 2022.
- ELECTROMEDICAL TECHNOLOGIES, INC. research and development expense for fiscal 2022 was $92.30K, a 57.13% decline from fiscal 2021.
- ELECTROMEDICAL TECHNOLOGIES, INC. research and development expense for fiscal 2021 was $215.32K, a 581.39% increase from fiscal 2020.
- ELECTROMEDICAL TECHNOLOGIES, INC. research and development expense for fiscal 2020 was $31.60K, a 61.86% decline from fiscal 2019.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $231.43K 10-K · filed 2024-05-01 | |||
| 2022-12-31 | $92.30K 10-K · filed 2024-05-01 | |||
| 2021-12-31 | $215.32K 10-K · filed 2023-03-31 | |||
| 2020-12-31 | $31.60K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $31.60K derived: sum of 2 quarters · filed 2022-03-31 | $35.60K derived: sum of 3 quarters · filed 2022-03-31 | $31.60K 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-16 | $4.00K derived: sum of 2 quarters · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $4.00K 10-Q/A · filed 2020-09-14 | $4.00K 10-Q/A · filed 2020-09-14 | ||
| 2019-12-31 | $47.24K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $61.77K derived: sum of 2 quarters · filed 2021-03-30 | $82.85K derived: sum of 3 quarters · filed 2021-03-30 | $82.85K 10-K · filed 2021-03-30 |
| 2019-09-30 | $14.53K 10-Q · filed 2020-11-16 | $35.61K derived: sum of 2 quarters · filed 2020-11-16 | $35.61K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $21.08K 10-Q/A · filed 2020-09-14 | $21.08K 10-Q/A · filed 2020-09-14 |